|
|
|
1-10 employees
View all
|
|
pharmaceuticals
|
|
10 Knightsbridge Road,Piscataway,NJ,US
|
|
Innopharma, Inc. was acquired by Pfizer, Inc on September 25, 2014.https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_innopharma --------------------------------------------------------------------------------------------------------------------------------------------------------InnoPharma, Inc. develops niche generic and specialty pharmaceutical/bio-pharmaceutical products in sterile dosage forms, and out-licenses to pharmaceutical marketing companies for commercialization.The “Niche Generics” program is targeted on developing those generic drug products that are:•Difficult to develop for technical reasons, especially injectable and ophthalmic dosage forms•None or very limited API source•Niche area of use•Complicated manufacturing•Complicated bio-equivalency or clinical studies•Potential to provide value to patients and prescribers, in terms of cost effectivenessVisit us at: http://innopharmainc.com
|
InnoPharma, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{first} | [email protected] |
50%
|
The widely used InnoPharma, Inc. email format is {first} (e.g. [email protected]) with 50% adoption across the company.
To contact InnoPharma, Inc. customer service number in your country click here to find.
Navneet Puri is the CEO of InnoPharma, Inc.. Or you may call +1.7328852939
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.